These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 36997106)

  • 41. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
    Hiroshima Y; Maawy A; Metildi CA; Zhang Y; Uehara F; Miwa S; Yano S; Sato S; Murakami T; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Laparoendosc Adv Surg Tech A; 2014 Apr; 24(4):241-7. PubMed ID: 24494971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
    Li L; Du Y; Chen X; Tian J
    Mol Imaging Biol; 2018 Dec; 20(6):930-939. PubMed ID: 29651576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of Fluorescence-Guided Surgery With Photodynamic Therapy for the Treatment of Cancer.
    He J; Yang L; Yi W; Fan W; Wen Y; Miao X; Xiong L
    Mol Imaging; 2017; 16():1536012117722911. PubMed ID: 28849712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer.
    Kularatne SA; Thomas M; Myers CH; Gagare P; Kanduluru AK; Crian CJ; Cichocki BN
    Clin Cancer Res; 2019 Jan; 25(1):177-187. PubMed ID: 30201762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
    Folaron M; Strawbridge R; Samkoe KS; Filan C; Roberts DW; Davis SC
    J Neurosurg; 2019 Sep; 131(3):724-734. PubMed ID: 30192200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indocyanine green-based fluorescence imaging in visceral and hepatobiliary and pancreatic surgery: State of the art and future directions.
    Baiocchi GL; Diana M; Boni L
    World J Gastroenterol; 2018 Jul; 24(27):2921-2930. PubMed ID: 30038461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improving Surgical Resection of Metastatic Liver Tumors With Near-Infrared Optical-Guided Fluorescence Imaging.
    Barabino G; Porcheron J; Cottier M; Cuilleron M; Coutard JG; Berger M; Molliex S; Beauchesne B; Phelip JM; Grichine A; Coll JL
    Surg Innov; 2016 Aug; 23(4):354-9. PubMed ID: 26603691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.
    van Driel PB; Boonstra MC; Prevoo HA; van de Giessen M; Snoeks TJ; Tummers QR; Keereweer S; Cordfunke RA; Fish A; van Eendenburg JD; Lelieveldt BP; Dijkstra J; van de Velde CJ; Kuppen PJ; Vahrmeijer AL; Löwik CW; Sier CF
    BMC Cancer; 2016 Nov; 16(1):884. PubMed ID: 27842504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
    Gao RW; Teraphongphom NT; van den Berg NS; Martin BA; Oberhelman NJ; Divi V; Kaplan MJ; Hong SS; Lu G; Ertsey R; Tummers WSFJ; Gomez AJ; Holsinger FC; Kong CS; Colevas AD; Warram JM; Rosenthal EL
    Cancer Res; 2018 Sep; 78(17):5144-5154. PubMed ID: 29967260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a drug-device combination for fluorescence-guided surgery in neuroendocrine tumors.
    Hernandez Vargas S; Lin C; Voss J; Ghosh SC; Halperin DM; AghaAmiri S; Cao HST; Ikoma N; Uselmann AJ; Azhdarinia A
    J Biomed Opt; 2020 Dec; 25(12):. PubMed ID: 33300316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraoperative Imaging Techniques to Support Complete Tumor Resection in Partial Nephrectomy.
    Hekman MCH; Rijpkema M; Langenhuijsen JF; Boerman OC; Oosterwijk E; Mulders PFA
    Eur Urol Focus; 2018 Dec; 4(6):960-968. PubMed ID: 28753888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
    Tang C; Du Y; Liang Q; Cheng Z; Tian J
    Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study.
    Mulder BGS; Koller M; Duiker EW; Sarasqueta AF; Burggraaf J; Meijer VE; Vahrmeijer AL; Hoogwater FJH; Bonsing BA; van Dam GM; Mieog JSD; Pranger BK
    J Nucl Med; 2023 Jan; 64(1):82-89. PubMed ID: 35680414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
    Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluorescence imaging in the surgical management of liver cancers: Current status and future perspectives.
    Wang Q; Li X; Qian B; Hu K; Liu B
    Asian J Surg; 2022 Jul; 45(7):1375-1382. PubMed ID: 34656410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography Results in Negative Surgical Margins and Decreased Local Recurrence in an Orthotopic Mouse Model of Osteosarcoma.
    Mahjoub A; Morales-Restrepo A; Fourman MS; Mandell JB; Feiqi L; Hankins ML; Watters RJ; Weiss KR
    Ann Surg Oncol; 2019 Mar; 26(3):894-898. PubMed ID: 30588559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design of Bimodal Ligands of Neurotensin Receptor 1 for Positron Emission Tomography Imaging and Fluorescence-Guided Surgery of Pancreatic Cancer.
    Renard E; Dancer PA; Portal C; Denat F; Prignon A; Goncalves V
    J Med Chem; 2020 Mar; 63(5):2426-2433. PubMed ID: 31855417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AND-gate contrast agents for enhanced fluorescence-guided surgery.
    Widen JC; Tholen M; Yim JJ; Antaris A; Casey KM; Rogalla S; Klaassen A; Sorger J; Bogyo M
    Nat Biomed Eng; 2021 Mar; 5(3):264-277. PubMed ID: 32989286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer.
    Wiktorowicz M; Mlynarski D; Pach R; Tomaszewska R; Kulig J; Richter P; Sierzega M
    Pancreatology; 2018 Dec; 18(8):977-982. PubMed ID: 30268674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.